Table 3.
Association between clinical/neuropathological variables and superior frontal cortex MLA binding and Aβ ELISA levels
Variable | MLA (N=24) | Aβ40 (N=20) | Aβ42 (N=20) | Total Aβ (N=20) |
---|---|---|---|---|
Age | -- | r = 0.48, p = 0.032 | r = 0.56, p = 0.011 | r = 0.55, p = 0.012 |
Sex | -- | -- | -- | -- |
Education | -- | -- | -- | -- |
APOE ε4 | -- | -- | -- | -- |
MMSE | (r = −0.25, p = 0.26) | (r = −0.36, p = 0.12) | r = −0.62, p = 0.0038 | r = −0.62, p = 0.0033 |
PMI | -- | -- | -- | -- |
Braak stage | (r = 0.40, p = 0.053) | (r = 0.36, p = 0.12) | r = 0.70, p = 0.0005 | r = 0.62, p = 0.0035 |
NIA Reagan Dx | r = −0.47, p = 0.021 | r = −0.52, p = 0.020 | r = −0.63, p = 0.0031 | r = −0.66, p = 0.0015 |
r: Spearman rank correlation coefficient
--: Not statistically significant